United States · FDA National Drug Code directory
ZYPREXA Zydis
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61269-651_40d4ed67-c51d-40d0-8a32-ecfdbf069f9a
- Product NDC
- 61269-651
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Olanzapine
- Labeler
- H2-Pharma LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20000601
- Source listing expiry
- 20271231
Source-listed ingredients
- OLANZAPINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 DOSE PACK in 1 CARTON (61269-651-35) / 1 BLISTER PACK in 1 DOSE PACK (61269-651-01) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 61269-651-35
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →